A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise's core biological effects in men with prostate cancer, raising levels of a molecule tied to energy ...

A clinical study suggests metformin may reproduce part of exercise’s metabolic signature in prostate cancer patients, raising Lac-Phe levels while supporting better weight control during hormone ...

Researchers have identified a surprising metabolic effect of a widely used diabetes drug in men undergoing prostate cancer treatment.